ArticleDrug delivery and translational research2022

A recombinant adenoviral vector with a specific tropism to CD4-positive cells: a new tool for HIV-1 inhibition.

Abtin Behmardi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.